Tag: gantenerumab June 21, 2021 Investigational Alzheimer’s drug improves biomarkers of the diseaseInternational clinical trial yields mixed results with unclear cognitive effects but promising biomarker results.News Release February 10, 2020 Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicatesTop-line data reported from international trial.News Release Posts navigation